Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of ...
Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...
The Food and Drug Administration approved the pill from Vertex Pharmaceuticals for acute pain that often occurs after surgery ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
The STAY study aims to change this reality. Researchers hope that the new drug will slow down the ageing process, improve ...
After 2024, which saw a steady recovery by the life sciences industry, it looks like 2025 is set to be a year of change and ...
RenovoRx's innovative RenovoCath and TAMP platform show promising clinical data. Click here to read why RNXT stock presents ...